ArticleBiology of sex differences2026
Sex-specific prediction models for aortic aneurysm integrating traditional clinical risk factors and proteomic profiles: a large-scale prospective study from the UK Biobank.
Article in Biology of sex differences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to systematically map the sex-specific clinical and proteomic risk profiles of aortic aneurysm (AA), elucidate its molecular mechanisms, and develop a sex-specific protein risk prediction score.
methodsBased on the UK Biobank, we adopted a sex-stratified strategy to assess associations between traditional clinical factors and AA in 471,660 participants, and performed proteomics analysis on 49,887 participants with plasma protein data. Mediation analysis was used to explore the molecular mechanisms by which clinical risks drive AA. Finally, sex-specific protein risk scores were developed via LASSO regression, and their predictive performance was evaluated in an independent validation cohort.
resultsSmoking (HR: Male: 2.82; Female: 4.42) and valvular disease (HR: Male: 2.01; Female: 4.62) were the strongest shared risk factors, with women exhibiting significantly higher susceptibility. Incident AA was primarily attributed to smoking (Male: 15.3%; Female: 19.8%) and hypertension (Male: 11.2%; Female: 10.2%). Smoking was associated with AA potentially through the ECM degradation pathway in both sexes. Hypertension may also influence AA risk through this pathway in men, whereas in women, it may primarily operate through metabolic and growth factor regulation pathways. Among LASSO-selected proteins, 4 were shared, 10 were male-specific, and 9 were female-specific. Ultimately, the model integrating traditional risk factors and sex-specific protein scores demonstrated superior predictive performance in an independent cohort (C-statistic: Male: 0.809; Female: 0.832).
conclusionsSmoking and hypertension are primary risk factors for AA. Men may be predisposed to structural destruction potentially mediated by ECM degradation, whereas women may be predisposed to intrinsic failure potentially involving metabolic dysregulation and cell apoptosis. The model integrating age, clinical factors, and protein scores better captures residual risk, significantly improving AA prediction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.